Compile Data Set for Download or QSAR
Report error Found 38 Enz. Inhib. hit(s) with all data for entry = 11203
TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600495(US11623923, Example 21)
Affinity DataIC50: 1.07nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600487(US11623923, Example 11)
Affinity DataIC50: 1.43nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600494(US11623923, Example 18)
Affinity DataIC50: 1.44nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600481(US11623923, Example 2)
Affinity DataIC50: 1.76nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600493(US11623923, Example 17)
Affinity DataIC50: 2.01nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600485(US11623923, Example 7)
Affinity DataIC50: 2.06nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600480(US11623923, Example 1)
Affinity DataIC50: 2.07nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600480(US11623923, Example 1)
Affinity DataIC50: 2.17nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600483(US11623923, Example 5)
Affinity DataIC50: 2.51nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600483(US11623923, Example 5)
Affinity DataIC50: 2.51nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600481(US11623923, Example 2)
Affinity DataIC50: 2.64nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600482(US11623923, Example 4)
Affinity DataIC50: 2.89nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600486(US11623923, Example 9)
Affinity DataIC50: 3.11nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600487(US11623923, Example 11)
Affinity DataIC50: 3.11nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600488(US11623923, Example 12)
Affinity DataIC50: 3.18nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600490(US11623923, Example 14)
Affinity DataIC50: 3.52nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600491(US11623923, Example 15)
Affinity DataIC50: 3.74nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600485(US11623923, Example 7)
Affinity DataIC50: 3.77nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600492(US11623923, Example 16)
Affinity DataIC50: 3.81nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600491(US11623923, Example 15)
Affinity DataIC50: 4.05nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600493(US11623923, Example 17)
Affinity DataIC50: 4.41nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600484(US11623923, Example 6)
Affinity DataIC50: 4.60nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600490(US11623923, Example 14)
Affinity DataIC50: 4.79nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600497(US11623923, Example 23)
Affinity DataIC50: 5nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600494(US11623923, Example 18)
Affinity DataIC50: 5.59nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600489(US11623923, Example 13)
Affinity DataIC50: 6.69nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600488(US11623923, Example 12)
Affinity DataIC50: 7.18nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600489(US11623923, Example 13)
Affinity DataIC50: 7.35nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600492(US11623923, Example 16)
Affinity DataIC50: 9.35nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600486(US11623923, Example 9)
Affinity DataIC50: 12.4nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600496(US11623923, Example 22)
Affinity DataIC50: 13.4nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600495(US11623923, Example 21)
Affinity DataIC50: 14.6nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600484(US11623923, Example 6)
Affinity DataIC50: 16.9nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600482(US11623923, Example 4)
Affinity DataIC50: 17.7nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600498(US11623923, Example 24)
Affinity DataIC50: 19nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600497(US11623923, Example 23)
Affinity DataIC50: 26.1nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600496(US11623923, Example 22)
Affinity DataIC50: 44nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent

TargetHepatocyte growth factor receptor(Human)
Medshine Discovery

US Patent
LigandPNGBDBM600498(US11623923, Example 24)
Affinity DataIC50: 59.3nMAssay Description:Reagents and Materials:Reaction buffer: 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2023
Entry Details
US Patent